EAM
MDGL icon

Erste Asset Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

Erste Asset Management’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$81M Buy
160,210
+19,110
+14% +$9.13M 0.75% 28
2025
Q4 		$82.3M Sell
141,100
-60,000
-30% -$30.6M 0.69% 32
2025
Q3 		$89.1M Hold
201,100
– – 0.86% 20
2025
Q2 		$60.8M Buy
201,100
+36,700
+22% +$10.9M 0.51% 42
2025
Q1 		$54.4M Hold
164,400
– – 0.7% 37
2024
Q4 		$51.3M Sell
164,400
-70,000
-30% -$19.7M 0.63% 40
2024
Q3 		$49.7M Sell
234,400
-10,980
-4% -$2.81M 0.6% 44
2024
Q2 		$68.9M Sell
245,380
-5,245
-2% -$1.25M 0.91% 25
2024
Q1 		$66.6M Sell
250,625
-74,375
-23% -$17.5M 0.91% 25
2023
Q4 		$75.3M Buy
325,000
+74,600
+30% +$13.1M 1.1% 13
2023
Q3 		$36.7M Buy
250,400
+239,400
+2,176% +$45.1M 0.63% 48
2023
Q2 		$2.42M Hold
11,000
– – 0.04% 265
2023
Q1 		$2.58M Hold
11,000
– – 0.05% 270
2022
Q4 		$3.26M Buy
+11,000
New +$1.08M 0.07% 244

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Erste Asset Management's MDGL Position: Q1 2026 in Review

Erste Asset Management increased its Madrigal Pharmaceuticals (MDGL) stake by 14% in Q1 2026, buying an estimated $9.13M and bringing the position to 160,210 shares worth $81M. The position accounts for 0.75% of the portfolio, ranked #28.

Erste Asset Management first reported a position in MDGL in Q4 2022 and has held it in 14 quarters since. The position peaked at $89.1M in Q3 2025. 378 funds tracked by Wall St. Rank hold MDGL as of Q1 2026.

  • Erste Asset Management held 160,210 shares of Madrigal Pharmaceuticals worth $81M as of Q1 2026.
  • Erste Asset Management bought 19,110 Madrigal Pharmaceuticals shares in Q1 2026, an estimated $9.13M.
  • Madrigal Pharmaceuticals made up 0.75% of Erste Asset Management's portfolio in Q1 2026, its #28 holding.
  • Erste Asset Management first reported a position in Madrigal Pharmaceuticals in Q4 2022 and has held it in 14 quarters since.
  • Erste Asset Management's Madrigal Pharmaceuticals position peaked at $89.1M in Q3 2025.
  • 378 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q1 2026.

Based on Erste Asset Management's 13F filing for Q1 2026, filed 11 May 2026.